Cargando…

Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib

Detalles Bibliográficos
Autores principales: Fay, Christopher J., Moslehi, Dorsa, Iriarte, Christopher, Dang, Timothy M., Virgen, Cesar A., Russell-Goldman, Eleanor, LeBoeuf, Nicole R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462782/
https://www.ncbi.nlm.nih.gov/pubmed/37650013
http://dx.doi.org/10.1016/j.jdcr.2023.06.038
_version_ 1785098109309681664
author Fay, Christopher J.
Moslehi, Dorsa
Iriarte, Christopher
Dang, Timothy M.
Virgen, Cesar A.
Russell-Goldman, Eleanor
LeBoeuf, Nicole R.
author_facet Fay, Christopher J.
Moslehi, Dorsa
Iriarte, Christopher
Dang, Timothy M.
Virgen, Cesar A.
Russell-Goldman, Eleanor
LeBoeuf, Nicole R.
author_sort Fay, Christopher J.
collection PubMed
description
format Online
Article
Text
id pubmed-10462782
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104627822023-08-30 Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib Fay, Christopher J. Moslehi, Dorsa Iriarte, Christopher Dang, Timothy M. Virgen, Cesar A. Russell-Goldman, Eleanor LeBoeuf, Nicole R. JAAD Case Rep Case Report Elsevier 2023-07-07 /pmc/articles/PMC10462782/ /pubmed/37650013 http://dx.doi.org/10.1016/j.jdcr.2023.06.038 Text en © 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Fay, Christopher J.
Moslehi, Dorsa
Iriarte, Christopher
Dang, Timothy M.
Virgen, Cesar A.
Russell-Goldman, Eleanor
LeBoeuf, Nicole R.
Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib
title Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib
title_full Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib
title_fullStr Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib
title_full_unstemmed Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib
title_short Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib
title_sort treatment-refractory cutaneous rosai–dorfman disease responsive to oral methotrexate and topical trametinib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462782/
https://www.ncbi.nlm.nih.gov/pubmed/37650013
http://dx.doi.org/10.1016/j.jdcr.2023.06.038
work_keys_str_mv AT faychristopherj treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib
AT moslehidorsa treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib
AT iriartechristopher treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib
AT dangtimothym treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib
AT virgencesara treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib
AT russellgoldmaneleanor treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib
AT leboeufnicoler treatmentrefractorycutaneousrosaidorfmandiseaseresponsivetooralmethotrexateandtopicaltrametinib